<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS: We investigated the relationship of urinary albumin excretion (UAE) to <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in Asian </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A total of 446 subjects (187 without <z:mp ids='MP_0002055'>diabetes</z:mp> and 259 with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>) were enrolled in this study </plain></SENT>
<SENT sid="2" pm="."><plain>The components of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e>, high sensitivity C-reactive protein (hs-CRP) and UAE were assessed </plain></SENT>
<SENT sid="3" pm="."><plain>Based on <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> status, participants were categorized into one of the following groups: neither <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> nor <z:mp ids='MP_0002055'>diabetes</z:mp> (MS-DM-), <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> without <z:mp ids='MP_0002055'>diabetes</z:mp> (MS+DM-), <z:mp ids='MP_0002055'>diabetes</z:mp> without <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (MS-DM+) and both <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and <z:mp ids='MP_0002055'>diabetes</z:mp> (MS+DM+) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The UAE in the MS+DM- group was higher than that in the MS-DM- group (P&lt;0.001) and lower than that in the MS+DM+ group (P&lt;0.001), but not significantly different from that in the MS-DM+ group (P=0.349) </plain></SENT>
<SENT sid="5" pm="."><plain>The trend of increasing UAE in these four groups was independent of hs-CRP </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: UAE was lowest in subjects with neither <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> nor <z:mp ids='MP_0002055'>diabetes</z:mp> and highest in subjects with both <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>; however, there was no significant difference between the <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> alone group and the type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> alone group </plain></SENT>
</text></document>